Harmonix

SentiAR is a digital health software company developing a 3D augmented reality holographic platform that provides real-time visualization of a patient’s anatomy and catheter location during interventional procedures. Spun out from Washington University, it uses real-time mapping data and imaging from CT/MRI to render holographic views over the patient in the catheterization laboratory, with clinician-controlled visualization. The platform aims to improve precision and safety in procedures addressing cardiac arrhythmias. The company focuses on delivering an immersive visualization solution for interventional cardiology and related specialties.

ATLAS Space Operations, Inc. is a company focused on transforming satellite communications and data management. Founded in 2015 and headquartered in Traverse City, Michigan, ATLAS develops the ATLAS Freedom Software Platform, a cloud-based system that enables users to efficiently gather and analyze information from space. This innovative platform features flexible scheduling, cloud processing, and a global network of antennas, allowing clients to optimize their satellite communications at a lower cost. By leveraging advanced technology and a unique approach to space-based communications, ATLAS aims to provide more accessible and scalable solutions for organizations engaged in satellite operations.

Attivare Therapeutics specializes in developing biomaterial vaccines designed for multiple applications. Its innovative approach involves creating a new physical microenvironment within the body to concentrate immune cells, delivering agents to reprogram the immune response, and enhancing patient responses to cancer antigens.

Sorcero, Inc. is a technology company founded in 2017 and headquartered in Washington, D.C. It specializes in developing a no-code platform that utilizes artificial intelligence to support decision-making and knowledge management for professionals in STEM fields, particularly in medical, insurance, and engineering industries. The Sorcero Language Intelligence Platform empowers subject matter experts by enabling the deployment of intelligent applications that can analyze and interpret complex data effectively. This platform is designed to enhance various operational processes, such as medical claims investigation, life insurance underwriting, and real-time monitoring of medical guidelines. Sorcero has received notable recognition within the digital health and insurtech sectors, being acknowledged as a leading startup by industry innovation leaders. The company's focus on improving patient outcomes and providing strategic insights through advanced analytics positions it as a significant player in the life sciences and medical analytics landscape.

xCures, Inc. is a healthcare technology company founded in 2018 and based in Los Altos, California, focused on transforming cancer treatment through its innovative AI-based precision oncology platform. The company addresses the challenges of traditional drug-centric treatment development by integrating cancer research and patient care. Its platform operates as a perpetual trial, continuously capturing Real World Evidence (RWE) from patients and treatments, allowing for real-time learning and adaptation. By coordinating treatment recommendations across various institutions, xCures ensures that patients receive personalized treatment options tailored to their specific needs. Additionally, the platform organizes insights from tumor boards, leveraging machine learning to assist healthcare professionals in making informed decisions. This approach not only enhances the effectiveness of cancer care but also aims to reduce the time and cost associated with drug development, ultimately improving patient outcomes.

Strateos specializes in automating chemistry, biology, and tissue analysis in closed-loop robotic labs, accelerating drug discovery programs for pharmaceutical partners. By combining advanced robotics, software for imaging and analytics, and remote cloud laboratories, Strateos enables more rapid and efficient discovery of new drug candidates. The company was formed through a merger of Transcriptic, which developed the first robotic cloud laboratory platform for life science research, and 3Scan, which specialized in automating tissue analysis. Strateos aims to express life science methods as data, enabling infrastructure virtualization and driving the next generation of discovery with significant time and cost efficiencies.

Sana Health, Inc. is a digital health company based in Lafayette, Colorado, with an additional office in Mill Valley, California. Founded in 2015, the company specializes in developing bio-therapeutic devices designed to promote relaxation and alleviate pain and tension. Its flagship product, Sana, is a non-addictive mask and headphone combination that utilizes audiovisual stimulation to enhance the balance between the left and right sides of the brain, facilitating a deep meditative state. This device employs coordinated pulses of light and sound to guide users into relaxation, mimicking the benefits of long-term meditation practices. Sana Health is also engaged in multiple clinical studies, focusing on applications for conditions such as fibromyalgia and neuropathic pain, as well as trials related to anxiety and PTSD. The company offers its products for sale online and provides a mobile application accessible via major app platforms.

Scribe Biosciences specializes in developing single-cell analysis tools for both clinical and research applications. The company utilizes Printed Droplet Microfluidics (PDM), a technology that allows for precise manipulation of fluids at the picoliter scale. This system employs fluorescence-activated microfluidic droplet sorting and a specialized substrate to handle individual cells and fluid samples with high throughput, enabling detailed studies in areas such as infectious diseases and cancer research.

Scribe Biosciences specializes in developing single-cell analysis tools for both clinical and research applications. The company utilizes Printed Droplet Microfluidics (PDM), a technology that allows for precise manipulation of fluids at the picoliter scale. This system employs fluorescence-activated microfluidic droplet sorting and a specialized substrate to handle individual cells and fluid samples with high throughput, enabling detailed studies in areas such as infectious diseases and cancer research.

SentiAR is a digital health software company developing a 3D augmented reality holographic platform that provides real-time visualization of a patient’s anatomy and catheter location during interventional procedures. Spun out from Washington University, it uses real-time mapping data and imaging from CT/MRI to render holographic views over the patient in the catheterization laboratory, with clinician-controlled visualization. The platform aims to improve precision and safety in procedures addressing cardiac arrhythmias. The company focuses on delivering an immersive visualization solution for interventional cardiology and related specialties.

ATLAS Space Operations, Inc. is a company focused on transforming satellite communications and data management. Founded in 2015 and headquartered in Traverse City, Michigan, ATLAS develops the ATLAS Freedom Software Platform, a cloud-based system that enables users to efficiently gather and analyze information from space. This innovative platform features flexible scheduling, cloud processing, and a global network of antennas, allowing clients to optimize their satellite communications at a lower cost. By leveraging advanced technology and a unique approach to space-based communications, ATLAS aims to provide more accessible and scalable solutions for organizations engaged in satellite operations.

Visicell Medical develops innovative stem cell tracking tools designed to enhance the safety and efficacy of regenerative therapies. Their biodegradable tools enable real-time tracking of injected stem cells in both clinical and pre-clinical settings, aiming to improve treatment outcomes for patients with incurable diseases.

Aether Bio is a technology company that focuses on re-purposing enzymes to create new compounds using machine learning. By integrating machine learning with high-throughput robotic laboratories, Aether Bio engineers enzymes rapidly and enables massively parallelized experimentation. This innovative approach generates significantly larger datasets compared to competitors, allowing researchers to manufacture complex and novel products more efficiently and at a lower cost. The company's technology aims to provide healthcare institutions with sustainable and affordable chemicals and materials essential for their operations.

Trials.ai is a technology company based in San Diego, California, specializing in the optimization of clinical trials through its innovative platform. Founded in 2015, the company offers a comprehensive system that integrates various functionalities, including electronic data capture, clinical trial management, patient-reported outcomes, and analytics, all designed to streamline trial management. By leveraging artificial intelligence, Trials.ai assists pharmaceutical, biotech, and medical device companies in designing efficient clinical trials, ultimately reducing the time and costs associated with bringing new treatments to market. The platform addresses challenges such as patient eligibility, visit management, and protocol adherence, guiding both researchers and patients through the trial process. Additionally, Trials.ai taps into vast amounts of previously underutilized data, providing unique insights and recommendations to trial sponsors for optimizing their trial protocols. This approach aims to enhance the success rate of clinical trials and ensure that effective treatments reach patients more quickly.

Qu Biologics Inc., founded in 2007 and based in Burnaby, Canada, specializes in developing immunotherapies aimed at restoring normal immune function. The company's primary focus is on Site Specific Immunomodulators (SSIs), which are designed to activate the body’s immune system to combat chronic inflammation associated with various conditions, including cancer and inflammatory bowel disease (IBD). Qu Biologics has treated over 270 patients with advanced cancer and moderate-to-severe immune-related diseases through a compassionate use program, showing promising preliminary outcomes. The company is currently recruiting for a Phase 1/2 clinical trial in Crohn’s disease, with the goal of improving survival rates and quality of life for individuals affected by cancer and debilitating immune-related diseases such as ulcerative colitis and rheumatoid arthritis.

Pathology Watch Inc. is a company that specializes in providing remote specimen interpretation services through its digital pathology solution, primarily for hospitals, laboratories, and dermatology centers. Founded in 2017 and headquartered in Salt Lake City, Utah, the company collaborates with dermatopathologists and subspecialized pathologists to interpret digital slides, pathology reports, and biopsy slides. By digitizing the pathology workflow, Pathology Watch enhances the quality of patient care while reducing costs and creating new revenue opportunities for clinical practices. Additionally, the company offers telepathology services tailored for large clinics and hospitals, ensuring efficient and effective pathology services.

Halo Industries, Inc. is a technology company based in San Mateo, California, focused on enhancing the energy output of solar thermal systems through innovative solutions. Established in 2014, it specializes in developing laser-based hardware systems that facilitate materials processing across various industries, including solar, semiconductors, LEDs, batteries, and power electronics. The company's automated production line tools aim to reduce costs while improving operational efficiency and product quality, supporting the advancement of next-generation technologies in these sectors.

xCures, Inc. is a healthcare technology company founded in 2018 and based in Los Altos, California, focused on transforming cancer treatment through its innovative AI-based precision oncology platform. The company addresses the challenges of traditional drug-centric treatment development by integrating cancer research and patient care. Its platform operates as a perpetual trial, continuously capturing Real World Evidence (RWE) from patients and treatments, allowing for real-time learning and adaptation. By coordinating treatment recommendations across various institutions, xCures ensures that patients receive personalized treatment options tailored to their specific needs. Additionally, the platform organizes insights from tumor boards, leveraging machine learning to assist healthcare professionals in making informed decisions. This approach not only enhances the effectiveness of cancer care but also aims to reduce the time and cost associated with drug development, ultimately improving patient outcomes.

Auransa Inc. is a clinical stage drug development company founded in 2014 and based in Palo Alto, California. The company focuses on inventing novel drugs for challenging diseases, including cancer, autoimmune disorders, and neurological conditions, utilizing its proprietary AI-driven drug discovery platform. This platform enables Auransa to analyze extensive genomics data from human disease tissues, facilitating the study of molecular disease subtypes and the prediction of effective compounds and targets for specific patient populations. Auransa's current pipeline includes a first-in-class investigational new drug for cancer that is undergoing clinical trials. Additionally, the company collaborates with various partners in the biopharma industry to enhance its research and development efforts.

Rad AI develops an artificial intelligence platform that automates report generation for radiologists. Its solution integrates with existing workflows, automating repetitive tasks to enhance efficiency, reduce burnout, and improve patient care.

Sana Health, Inc. is a digital health company based in Lafayette, Colorado, with an additional office in Mill Valley, California. Founded in 2015, the company specializes in developing bio-therapeutic devices designed to promote relaxation and alleviate pain and tension. Its flagship product, Sana, is a non-addictive mask and headphone combination that utilizes audiovisual stimulation to enhance the balance between the left and right sides of the brain, facilitating a deep meditative state. This device employs coordinated pulses of light and sound to guide users into relaxation, mimicking the benefits of long-term meditation practices. Sana Health is also engaged in multiple clinical studies, focusing on applications for conditions such as fibromyalgia and neuropathic pain, as well as trials related to anxiety and PTSD. The company offers its products for sale online and provides a mobile application accessible via major app platforms.

Volumetric, Inc. is an advanced biomaterials and biofabrication company based in Houston, Texas, established in 2014. It specializes in developing a 3D bioprinting platform designed to create vascularized human tissue, which can be utilized in various applications such as life sciences, drug discovery, and medical devices. The company offers bioprinters and bioinks that aim to facilitate innovations in biomaterials, cancer research, and the potential replacement of human organs. By focusing on creating materials embedded with living cells, Volumetric is at the forefront of integrating cutting-edge technology into healthcare solutions.

Ancilia Biosciences is a biotechnology company focused on developing engineered bacterial therapies aimed at treating diseases associated with the microbiome. The company specializes in creating virus-resistant live bacterial products that modulate the human microbiome, specifically targeting the viral components of the gut microbiome. By concentrating on enhancing healthy gut bacteria and their predatory phages, Ancilia develops therapeutic strains that can effectively combat chronic diseases in the fields of immunology and oncology. Additionally, the company is pioneering a new class of live biotherapeutics that allow for the precise targeting of phages or viruses known to induce lysis, thereby advancing treatment options in microbiome-related health conditions.

GEn1E Lifesciences Inc. is a biotechnology company based in Palo Alto, California, that focuses on developing therapies for inflammatory and age-related diseases. Incorporated in 2018, GEn1E employs a unique artificial intelligence platform to accelerate the creation of immunomodulatory therapies targeted at rare diseases that currently lack effective treatments. The company has built a robust pipeline of over 21 novel immunomodulators and is working to expedite the development of additional therapies to address pressing health challenges. One of its key products, MUC1-ED, is an antibacterial therapy designed to combat pseudomonas infections. GEn1E's innovative approach allows for the rapid advancement of drug development, significantly reducing time and costs compared to traditional methods in the pharmaceutical industry. The company's experienced team, formed from notable backgrounds in drug development and machine learning, has made substantial progress in a short period, with the aim of delivering life-saving treatments to patients in need.

Juvena Therapeutics is a biopharmaceutical company developing protein-based therapies to promote tissue rejuvenation and repair in elderly individuals. Founded in 2017, the company focuses on treating age-related conditions such as sarcopenia, wound healing, and neural regeneration.

Bioz is a cloud-based, AI-driven search and data-mining platform for life sciences that analyzes peer-reviewed literature, including full text and materials and methods sections, to identify reagents, instruments, equipment, and consumables. It provides relevancy-ranked results, research-relevant correlations, product ratings, and collaboration optimization, helping scientists quickly find, compare, and select the right products. By structuring data from the articles, Bioz accelerates experimentation and speeds drug discovery for researchers in academia and biopharma. Founded in 2013 and based in Palo Alto, Bioz aims to streamline procurement and enable faster scientific progress by turning complex literature into actionable product insights.

Pragma Bio is a biotechnology company that uses microbiome-based approaches to discover therapies for cancer and autoimmune diseases, combining genomic sequencing, artificial intelligence, and synthetic biology to identify biomarkers and develop therapeutics through a data-driven platform that aggregates public and private data to build a microbiome database and reveal connections across microbial and clinical data. The company pursues small-molecule discovery from human-associated bacteria, focusing on the gut-immune axis, and aims to deliver health-indicative molecules with robust safety profiles, while the platform supports risk stratification and outcome prediction for patients by leveraging real-world data. Pragma Bio was founded in 2018 in Millbrae, California by Peter McCaffrey, Kovi Bessoff, Ayin Vala and Kareem Barghouti.

Founded in 2017, Viscient Biosciences is a biotechnology company based in San Diego, California. It specializes in drug discovery across various therapeutic areas, focusing on non-alcoholic steatohepatitis (NASH). The company combines human 3D tissue technology with multi-omics analysis to revolutionize drug development.

Nelumbo is a materials innovation company focused on HVAC efficiency and corrosion resistance. It develops a platform of structural materials and advanced surface coatings, including thin superomnophobic nanocoatings for cooling coils, and designs improved heat exchangers for refrigeration and air conditioning equipment. The coatings aim to reduce frost buildup and defrost downtime, while the heat exchangers target better energy performance and lower maintenance. The company positions its technologies to unlock mass-market opportunities with potential carbon emission and energy-use reductions worldwide. It was founded in 2015 and is based in Menlo Park, California.

ATLAS Space Operations, Inc. is a company focused on transforming satellite communications and data management. Founded in 2015 and headquartered in Traverse City, Michigan, ATLAS develops the ATLAS Freedom Software Platform, a cloud-based system that enables users to efficiently gather and analyze information from space. This innovative platform features flexible scheduling, cloud processing, and a global network of antennas, allowing clients to optimize their satellite communications at a lower cost. By leveraging advanced technology and a unique approach to space-based communications, ATLAS aims to provide more accessible and scalable solutions for organizations engaged in satellite operations.

Prime Movers Lab is a Wyoming-based venture capital firm founded in 2018 and headquartered in Jackson. It targets early-stage investments in deep-technology startups spanning energy, transportation, infrastructure, manufacturing, and agriculture, as well as adjacent areas such as human augmentation, autonomous systems, aerospace, drones, water, quantum computing, advanced materials, clean energy, and new space technology. The firm also backs health innovation and sustainable food initiatives. It makes equity investments in a range of roughly $0.25 million to $5 million and does not take board seats, lead rounds, co-invest, or seek controlling stakes, nor does it invest in publicly listed securities.

SentiAR is a digital health software company developing a 3D augmented reality holographic platform that provides real-time visualization of a patient’s anatomy and catheter location during interventional procedures. Spun out from Washington University, it uses real-time mapping data and imaging from CT/MRI to render holographic views over the patient in the catheterization laboratory, with clinician-controlled visualization. The platform aims to improve precision and safety in procedures addressing cardiac arrhythmias. The company focuses on delivering an immersive visualization solution for interventional cardiology and related specialties.

Halo Industries, Inc. is a technology company based in San Mateo, California, focused on enhancing the energy output of solar thermal systems through innovative solutions. Established in 2014, it specializes in developing laser-based hardware systems that facilitate materials processing across various industries, including solar, semiconductors, LEDs, batteries, and power electronics. The company's automated production line tools aim to reduce costs while improving operational efficiency and product quality, supporting the advancement of next-generation technologies in these sectors.

Abalone Bio, Inc. is a biotechnology company based in Richmond, California, founded in 2017. The company specializes in the development of antibody drugs aimed at treating a range of conditions, including pain, inflammatory diseases, rare cancers, and rare kidney diseases. Abalone Bio utilizes libraries of yeast cells that express various antibody variants to create recombinant protein versions of its antibodies. This innovative approach allows the company to effectively activate or inhibit drug targets, confirming their efficacy through human cell assays. By focusing on unlocking new disease treatments, particularly for peripheral neuropathy and other rare diseases, Abalone Bio aims to advance the field of medicine through the integration of gene sequencing and synthetic biology.

Tarana Wireless, Inc. is a technology company that specializes in researching, developing, and commercializing non-line-of-sight (NLoS) wireless transport solutions. Its flagship product, AbsoluteAir 2, offers advanced wireless transport capabilities with features such as deterministic True NLOS performance, extensive coverage, multi-kilometer range, and high spectral efficiency. The company provides construction-grade installation services and a carrier-class management system that allows operators to configure, monitor, and manage their network nodes effectively. Tarana's solutions are designed to support various applications, including small-cell backhaul, wireless fiber extension, and fixed wireless broadband access. The company serves tier-1 telecommunications operators globally and is headquartered in Milpitas, California, with additional offices in Berkeley, California, and Pune, India. Tarana Wireless was established in 2009 and has made significant advancements in wireless technology, offering lower total cost of ownership and unmatched scalability for its clients.

DermaSensor develops a handheld device that uses artificial intelligence to evaluate skin lesions for signs of cancer. Its primary product, DermaSensor, enables physicians and consumers to perform skin checks in offices and homes, potentially saving lives and healthcare costs by increasing accessibility to effective skin cancer evaluation.

Mathison is a comprehensive platform designed to enhance diversity hiring and retention. It offers tools for sourcing underrepresented candidates, reducing bias in the hiring process, and fostering team engagement around diversity efforts.

Founded in 2009, Terramera develops plant-based pesticides and fertilizers. It offers products like Proof (for bed bugs and dust mites), Actigate (an organic pesticide), and Rango (a plant-based pest control). The company aims to transform agriculture by fusing artificial intelligence, science, and nature to provide sustainable alternatives to chemical pesticides and fertilizers.

REITIUM is a real estate marketplace that democratizes access to property investment, allowing individuals to become real estate investors with as little as $100. Targeting a diverse audience, including millennials, seniors, and residents of developing countries, the platform aims to unlock the potential of approximately $3 trillion in untapped capital. Utilizing blockchain technology, REITIUM simplifies the investment process by eliminating traditional barriers, enabling users to securely invest in global real estate assets. Users can easily create an account, fund their wallets, browse available properties, and enjoy the benefits of fractional ownership, which includes sharing in rental income and property appreciation. This innovative approach allows investors to grow their wealth and provides the flexibility to sell their investments at any time.

Unlimited Tomorrow, Inc. is a company focused on developing advanced prosthetic technologies for amputees, utilizing 3D scanning, 3D printing, and machine learning. Founded in 2014 and based in Rhinebeck, New York, the company creates robotic arms and legs that can be controlled through the user's thoughts. By employing 3D scanners to digitally map an amputee's residual limb and the opposite full arm, Unlimited Tomorrow tailors each artificial limb to fit the individual precisely. Their open-source approach aims to make these cutting-edge technologies accessible and affordable, particularly for individuals in remote and underprivileged communities who may otherwise lack access to prosthetic solutions. The company's commitment to prioritizing user needs ensures that its innovations effectively cater to the diverse requirements of differently-abled individuals.

Upward Farms is an innovative indoor aquaponic farm that specializes in cultivating leafy greens and fish while adhering to high ecological and quality standards. By integrating modern vertical farming techniques with the ancient practice of aquaponics, the company creates a self-sustaining ecosystem where fish naturally fertilize the crops. This method allows Upward Farms to produce USDA-certified organic microgreens and hybrid striped bass without the use of antibiotics, hormones, or mercury. The result is a range of convenient, local, and ready-to-eat food products designed to nourish people, families, and the planet while promoting sustainability.

Upward Farms is an innovative indoor aquaponic farm that specializes in cultivating leafy greens and fish while adhering to high ecological and quality standards. By integrating modern vertical farming techniques with the ancient practice of aquaponics, the company creates a self-sustaining ecosystem where fish naturally fertilize the crops. This method allows Upward Farms to produce USDA-certified organic microgreens and hybrid striped bass without the use of antibiotics, hormones, or mercury. The result is a range of convenient, local, and ready-to-eat food products designed to nourish people, families, and the planet while promoting sustainability.

Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Momentus offers in-space infrastructure services, including transportation for satellites between orbits, hosted payloads, and in-orbit services. Founded in 2017, the company is based in Santa Clara, California.

Founded in 2017, Babylon Micro-Farms operates indoor farms for farmers to grow a variety of crops such as leafy greens, herbs, microgreens, and edible flowers. The company offers smart, scalable farming solutions tailored to clients' needs, utilizing remote management technology to power a distributed network of micro-farms across North America.

Prime Movers Lab is a Wyoming-based venture capital firm founded in 2018 and headquartered in Jackson. It targets early-stage investments in deep-technology startups spanning energy, transportation, infrastructure, manufacturing, and agriculture, as well as adjacent areas such as human augmentation, autonomous systems, aerospace, drones, water, quantum computing, advanced materials, clean energy, and new space technology. The firm also backs health innovation and sustainable food initiatives. It makes equity investments in a range of roughly $0.25 million to $5 million and does not take board seats, lead rounds, co-invest, or seek controlling stakes, nor does it invest in publicly listed securities.

PolySpectra is a materials company that develops functional materials and light-activated catalysts for advanced additive manufacturing. The company provides stereolithography resins and other light-curable materials designed to print durable plastic parts and enable production-scale 3D printing with tailored properties from a single chemical system. Founded in 2016 and headquartered in Berkeley, California, PolySpectra aims to transform 3D printing from prototyping to production by offering modular materials platforms that support a broad range of mechanical, thermal, and functional properties for engineers and designers.

Partsium is a B2B market place that facilitates the commercialization of automotive parts.

Amaz Project offers energy drinks that include yerba mate, green tea, guarana, acerola berries, suma root, and yanomami mushrooms. They sell their products online. The company's contact modes are mail and physical address.

PreciPoint GmbH is a leading provider of digital microscopy solutions, specializing in the design, development, and manufacturing of advanced digital microscopes and associated software. Founded in 1982 and based in Freising, Germany, the company operates a manufacturing facility in Thüringen. PreciPoint offers a comprehensive range of products, including smart microscopes, x-y-stages, electronic control systems, and automated testing systems. It also provides software solutions such as ViewPoint for virtual slide viewing and ScanPoint for whole slide scanning. By integrating laboratory information management software and AI-powered image analysis, PreciPoint enhances the capabilities of pathology labs, enabling them to deliver efficient and innovative diagnostic services. The company’s unique approach focuses on understanding laboratory workflows, facilitating improved outcomes in cancer diagnostics and pathology.

LifeGuides, PBC is a company based in Ocala, Florida, that specializes in providing stress consulting services tailored for employees facing various life challenges. Founded in 2016, LifeGuides offers an innovative Marketplace for Life Experience, featuring a community of trained and certified Guides who assist individuals in over 400 topics related to personal growth, lifelong learning, and everyday life events. These services are positioned as an HR benefit, enabling leading employers across diverse industries to support their employees' wellbeing. By connecting employees with experienced Guides who have successfully navigated similar life situations, LifeGuides fosters a unique environment of empathetic support. This approach not only enhances employee happiness but also promotes productivity, making it a valuable resource for organizations aiming to cultivate a positive workplace culture.